{"nct_id":"NCT02713867","title":"A Dose Frequency Optimization,Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks","status":"COMPLETED","status_verified_date":"2023-01","start_date":"2016-05-24","start_date_type":"ACTUAL","primary_completion_date":"2019-07-15","primary_completion_date_type":"ACTUAL","completion_date":"2022-01-18","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}